NASDAQ: AZRX

SEARCH

SIGN UP

AzurRx Logo
  • About
      • Back
      • President's Message
      • Board of Directors
      • The Team
  • Science & Technology
      • Back
      • Overview
      • Programs
      • Development Pipeline
      • Cystic Fibrosis
      • Chronic Pancreatitis
      • Nosocomial Infections
      • Non-Systemic Biologics
      • Digestive Enzymes
      • Antibiotics and the Gut
  • Investors
      • Back
      • Press Releases
          • Back
          • 2019
          • 2018
          • 2017
          • 2016
          • 2015
          • 2014
      • Events
          • Back
          • Upcoming Events
          • Past Events
      • Presentation
      • Regulatory Filings
      • Financial Statements
          • Back
          • 2019
              • Back
              • Q1 2019
          • 2018
              • Back
              • Q4 2018
              • Q3 2018
              • Q2 2018
              • Q1 2018
          • 2017
              • Back
              • Q4 2017
              • Q3 2017
              • Q2 2017
              • Q1 2017
          • 2016
              • Back
              • Q4 2016
              • Q3 2016
      • Stock Info
      • Analyst Coverage
      • Corporate Governance
      • Contact Us
  • Clinical Studies
      • Back
      • Completed Clinical Studies
      • Clinical Publications
  • Collaborations
      • Back
      • Partnering with AzurRx
  • Contact
      • Back
      • Contact Us
      • Subscribe
  • Home
  • Investors
  • Press Releases
  • 2014

Menu

  • Press Releases
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
  • Events
    • Upcoming Events
    • Past Events
  • Presentation
  • Regulatory Filings
  • Financial Statements
    • 2019
      • Q1 2019
    • 2018
      • Q4 2018
      • Q3 2018
      • Q2 2018
      • Q1 2018
    • 2017
      • Q4 2017
      • Q3 2017
      • Q2 2017
      • Q1 2017
    • 2016
      • Q4 2016
      • Q3 2016
  • Stock Info
  • Analyst Coverage
  • Corporate Governance
  • Contact Us

2014 News

Filters
List of articles in category 2014 News
Title Date
AzurRx Announces Issuance of U.S. Patent for its MS1819 lipase compound 31 Jul, 2014
  • About
  • Science & Technology
  • Investors
  • Clinical Studies
  • Collaborations
  • Contact

Contact Us

AzurRx BioPharma, Inc.

760 Parkside Avenue
Downstate Biotechnology Incubator
Suite 304
Brooklyn, NY 11226 

Tel: 646-699-7855
info@azurrx.com

AzurRx SAS

Jardin des Entreprises, Bat 1
290, Chemin de Saint-Dionisy
30980 Langlade, France

Tel: +33 (0)4 66 67 08 16

SiteMap Ⓒ 2019 AzurRx All Rights Reserved. Website by Sandman Media Inc.